Name: CRNX Balance Sheet - Crinetics Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CRNX - Crinetics Pharmaceuticals, Inc.

USD | NASDAQ | Healthcare

CRNX Balance Sheet - Crinetics Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015
Cash And Short Term Investments
Cash And Equivalents	101.5	264.5	54.9	32.7	200.7	93.1	40.3	45.0	14.2	-	-
Restricted Cash	0.0	0.5	-	-	-	-	-	-	-	-	-
Short Term Investments	926.4	1,089.5	503.7	301.8	133.0	77.8	78.1	118.9	-	-	-
Cash And Short Term Investments	1,027.9	1,354.1	558.6	334.4	333.7	170.9	118.4	163.9	14.2	-	-
Receivables
Accounts Receivable	0.6	0.0	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	2.0	0.0	-	-	-	-	-	-	-	-	-
Prepaid Expenses	17.8	20.8	15.6
Non-Current Assets
Property, Plant & Equipment Gross	22.2	19.8	15.9	7.6	6.3	5.7	5.6	5.0	0.7	-	-
Accumulated Depreciation	8.0
Current Liabilities
Accounts Payable	22.6	5.9	6.5	6.9	3.4	-	-	1.5	0.4	-	-
Short Term Debt	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	42.1	44.6
Common Equity
Common Stock	-	-	0.3	0.0	-	-	-	0.0	0.0	-	-
Additional Paid In Capital	-	-	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q4 FY 16	Q4 FY 15
Cash And Short Term Investments
Cash And Equivalents	114.3	101.5	110.9	53.7	94.6	264.5	317.3	302.2	395.9	54.9	142.8	39.6	41.2	32.7	30.9

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	3.1	2.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	22.4	17.8	28.5	20.4	16.4	20.8	14.9	11.8	16.3	15.6	21.1	20.3	9.3	10.8	10.0	7.8	8.5	11.0
Other Current Assets	6.4	3.5	4.8	3.7	2.7	2.3	1.5	1.5	3.6	0.4	3.5	2.8	3.3	1.9	1.7	1.6	1.6
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	1,322.4	1,048.3	1,121.3	1,217.3	1,291.1	1,375.4	877.6	874.8	917.2	574.2	575.8	284.8	305.4	345.2	378.3	416.3

Non-Current Assets
Property, Plant & Equipment Gross	22.6	22.2	21.4	24.3	21.3	19.8	18.7	18.5	17.3	15.9	14.6	7.8	7.6	7.6	7.4	7.1	6.4	6.3	6.1	-	6.0	5.7	5.7	5.7	5.6	5.6	5.4	5.4	5.4	5.0	4.9	2.2	-	0.7	-	-
Accumulated Depreciation	9.1	8.0	7.0	9.6	8.6	7.7	7.0	6.2	5.5	5.1	4.9	4.6	4.4	4.1	3.8	3.9	3.7
Property,Plant & Equipment Net	13.5	14.3	14.4	14.7	12.6	12.1	11.7	12.2	11.9	10.9	9.8	3.2	3.3	3.5	3.6	3.2
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	39.8	40.5	41.1	41.9	42.7	43.5	44.3	45.0	45.8	46.5	48.0	1.3	1.4	1.5	1.6	1.7
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	-	-	-	-	14.2	2.8	2.5	2.2	2.0	2.0	2.0	2.0	2.0	0.0	-	-	-
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	1,401.3	1,126.3	1,196.0	1,289.6	1,361.3	1,434.6	937.4	935.5	978.2	635.4	641.5	293.3	314.0	352.2	384.9	421.7

Current Liabilities
Accounts Payable	12.9	22.6	6.1	11.3	9.8	5.9	4.9	8.9	10.8	6.5	5.8	4.8	5.9	6.9	5.9	9.0	-	3.4	-	-	-	-	-	-	-	-	2.1	2.7	2.0	1.5	1.4	2.6	-	0.4	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	1.3	1.2	-	-	-	-	1.7	2.6	-	2.1	-	-	-	-	-	-	-
Operating Lease Liabilities Current	6.5	6.5	6.4	6.6	6.9	7.2	7.4	7.4	5.8	4.2	4.0	1.1	1.1	1.1	1.0	1.0
Accrued Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.0	1.0
Total Current Liabilities	71.1	85.1	74.2	68.4	57.3	59.7	53.6	54.4	51.8	43.9	40.5	32.6	26.3	27.7	24.6

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	41.3	42.1	42.7	43.3	43.9	44.6	45.1	45.9	46.7	47.6	48.2	1.5	1.7	2.0	2.3	2.6
Deferred Revenue Non-Current	3.3	3.8	4.1	4.0	4.3	4.7	5.2	4.3	4.7	4.8	5.1	5.1	5.6	6.1	6.7	6.9	7.2
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	4.9	3.2	2.9	2.3	1.8	0.8	0.5	0.2	-	0.0	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	120.7	134.2	123.9	118.0	107.3	109.8	104.4	104.8	103.2	96.2	93.8	39.1	33.7	35.8	33.5	35.6

Common Equity
Common Stock	-	-	-	-	-	-	-	-	0.9	0.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	0.0	-	0.0	-	-
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(1,545.3)	(1,417.4)	(1,294.6)	(1,164.5)	(1,048.9)	(952.1)	(871.5)	(794.7)	(720.6)	(653.7)	(593.6)	(536.1)	(485.2)	(439.2)	(394.2)	(352.3)	(309.9)
Accumulated Other Comprehensive Income	(1.3)	1.9	2.2	1.6	2.0	1.0	2.0	(0.2)	0.2	1.0	(0.9)	(1.7)	(2.5)	(3.9)	(5.0)	(3.6)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	1,280.6	992.1	1,072.2	1,171.5	1,254.0	1,324.8	833.0	830.8	874.9	539.1	547.7	254.1	280.3	316.3	351.4	386.2	303.0
Total Equity	1,280.6	992.1	1,072.2	1,171.5	1,254.0	1,324.8	833.0	830.8	874.9	539.1	547.7	254.1	280.3	316.3	351.4	386.2	303.0	331.9